Skip to main content
. 2020 Jan 13;15(1):e0226084. doi: 10.1371/journal.pone.0226084

Table 2. Patient history, CT patterns, distribution and extent of NSIP and UIP (one- and two-arm studies).

NSIP UIP Wilcoxon test
n observations, median (min; max) n observations, median (min; max) p-value
Number of patients 725 1593  
Total number of studies (n) n = 20 n = 25
Age n = 14, 54.6 (48.0; 59.2) n = 19, 62.7 (53.1; 75.5) <0.001
Male (%) n = 14, 34.7 (4.3; 64.0) n = 18, 73.6 (50.8; 86.1) <0.001
Smoking (ever and past smokers) (%) n = 9, 50.0 (8.2; 58.1) n = 14, 73.2 (24.2; 91.7) 0.001
TOT disease extent (mean % of lung volume) n = 9, 27.9 (0.4; 37.1) n = 9, 32.0 (0.2; 44.0) 0.566
GGO (y/n) (%) n = 8, 91.9 (44.3; 100.0) n = 6, 31.0 (0.0; 100.0) 0.065
GGO extent (mean % of lung volume) n = 12, 19.9 (5.6; 31.8) n = 10, 14.7 (1.4; 23.4) 0.086
Honeycombing (y/n) (%) n = 9, 8.5 (0.0; 32.0) n = 10, 66.7 (15.9; 98.4) 0.001
Honeycombing extent (mean % of lung volume) n = 10, 0.4 (0.0; 12.5) n = 10, 5.6 (1.0; 30.3) 0.006
Consolidation y/n (%) n = 8, 37.4 (4.0; 74.6) n = 7, 2.9 (0.0; 58.8) 0.049
Consolidation extent (mean % of lung volume) n = 11, 3.0 (0.0; 10.8) n = 10, 1.1 (0.0; 6.0) 0.09
Reticulation (y/n) (%) n = 7, 86.9 (10.0; 100.0) n = 5, 100.0 (46.2; 100.0) 0.449
Reticulation extent (mean % of lung volume) n = 7, 7.3 (3.3; 11.8) n = 5, 10.8 (6.8; 30.1) 0.123
Predominant GGO: GGO>(R+H) (%) n = 2, 21.7 (14.8; 28.6) n = 3, 8.7 (4.8; 9.4) 0.083
Predominant reticulation: (R+H)>GGO (%) n = 2, 37.4 (28.6; 46.3) n = 2, 74.6 (56.3; 92.9) 0.121
H and/or R > G (%) n = 2, 2.0 (0.0; 4.0) n = 2, 27.6 (14.3; 40.9) 0.121
Subpleural sparing (y/n) (%) n = 5, 30.8 (21.3; 64.0) n = 3, 4.3 (0.0; 9.3) 0.025
Emphysema (y/n) (%) n = 2, 11.7 (11.5; 11.9) n = 4, 19.3 (0.0; 32.3) 0.355
Emphysema extent (mean % of lung volume) n = 5, 1.8 (1.0; 3.2) n = 5, 2.8 (1.6; 6.8) 0.251
Mosaic GGO (y/n) (%) n = 1, 36.0 (36.0; 36.0) n = 4, 16.4 (8.0; 43.5) 0.48
Peripheral predominance (outer 1/3) (%) n = 8, 44.7 (33.3; 76.0) n = 8, 82.5 (75.0; 95.5) 0.001
Central predominance/perbronchial (inner 2/3) (%) n = 7, 37.0 (0.0; 61.1) n = 7, 5.0 (4.1; 14.7) 0.064
Diffuse axial distribution both (%) n = 7, 27.1 (5.6; 47.5) n = 7, 6.7 (0.0; 21.7) 0.035
Upper lung predominant distribution (%) n = 5, 0.0 (0.0; 2.8) n = 5, 1.0 (0.0; 8.3) 0.435
Lower lung predominant (below carina) (%) n = 5, 91.8 (80.0; 96.0) n = 5, 84.0 (78.6; 100.0) 0.917
Diffuse distribution: both upper and lower lungs (%) n = 5, 8.2 (6.3; 11.9) n = 5, 16.2 (0.0; 20.4) 0.6

GGO: ground-glass opacity, H: honeycombing; R: reticulation; y/n: yes/no